Issue Archive

2014

Volume 54 - Issue 6 - June 2014

Volume 54 - Issue 5 - May 2014

Volume 54 - Issue 4 - April 2014

Volume 54 - Issue 3 - March 2014

Volume 54 - Issue 2 - February 2014

Volume 54 - Issue 1 - January 2014

2013

Volume 53 - Issue 12 - December 2013

Volume 53 - Issue 11 - November 2013

Volume 53 - Issue 10 - October 2013

Volume 53 - Issue 9 - September 2013

Volume 53 - Issue 8 - August 2013

Volume 53 - Issue 7 - July 2013

Volume 53 - Issue 6 - June 2013

Volume 53 - Issue 5 - May 2013

Volume 53 - Issue 3 - April 2013

Volume 53 - Issue 3 - March 2013

Volume 53 - Issue 2 - February 2013

Volume 53 - Issue 1 - January 2013

2012

Volume 52 - Issue 12 - December 2012

Volume 20 - Number 12 - December 2012

Volume 52 - Issue 11 - November 2012

Volume 52 - Issue 10 - October 2012

Volume 52 - Issue 9 - September 2012

Volume 52 - Issue 8 - August 2012

Volume 52 - Issue 7 - July 2012

Volume 52 - Issue 6 - June 2012

Volume 52 - Issue 5 - May 2012

Volume 52 - Issue 4 - April 2012

Volume 52 - Issue 3 - March 2012

Volume 52 - Issue 2 - February 2012

Volume 52 - Issue 1 - January 2012

2011

Volume 51 - Issue 12 - December 2011

Volume 51 - Issue 11 - November 2011

Volume 51 - Issue 10 - October 2011

Volume 51 - Issue 9 - September 2011

Volume 51 - Issue 8 - August 2011

Volume 51 - Issue 7 - July 2011

Volume 51 - Issue 6 - June 2011

Volume 51 - Issue 5 - May 2011

Volume 51 - Issue 4 - April 2011

Volume 51 - Issue 3 - March 2011

Volume 51 - Issue 2 - February 2011

Volume 51 - Issue 1 - January 2011

2010

Volume 50 - Issue 12 - December 2010

Volume 50 - Issue 11 - November 2010

Volume 50 - Issue 10 - October 2010

Volume 50 - Issue 9 - September 2010

Volume 50 - Issue 8 - August 2010

Volume 50 - Issue 7 - July 2010

Volume 50 - Issue 6 - June 2010

Volume 50 - Issue 5 - May 2010

Volume 50 - Issue 4 - April 2010

Volume 50 - Issue 3 - March 2010

Volume 50 - Issue 2 - February 2010

Volume 50 - Issue 1 - January, 2010

2009

Volume 49 - Issue 12 - December 2009

Volume 49 - Issue 11 - November 2009

Volume 49 - Issue 10 - October 2009

Volume 49 - Issue 9 - September 2009

Volume 49 - Issue 8 - August 2009

Volume 49 - Issue 7 - July 2009

Volume 49 - Issue 6 - June 2009

Volume 49 - Issue 5 - May 2009

Volume 49 - Issue 4 - April 2009

Volume 49 - Issue 3 - March 2009

Volume 49 - Issue 2 - February 2009

Volume 49 - Issue 1 - January 2009

2008

Volume 48 - Issue 13 - December 2008

Volume 48 - Issue 11 - October 2008

Volume 48 - Issue 8 - August 2008

Volume 48 - Issue 4 - April 2008

2007

Volume 47 - Issue 12 - December 2007

Research Summaries

FDA Approval

physician talking to woman

FDA Approval

FDA Approves Sacituzumab Govitecan (Trodelvy) for First-Line Treatment of Locally Advanced or Metastatic Triple-Negative Breast Cancer

06/26/2026

Anthony Calabro, MA

The FDA approved sacituzumab govitecan-hziy (Trodelvy) as monotherapy, and with pembrolizumab-based therapy, for select adults with previously untreated unresectable locally advanced or metastatic...

06/26/2026

Conference Coverage

Brett Snodgrass, DNP, FNP-C, and Steven Stanos, DO

Conference Coverage

Case-Based Evaluation and Multimodal Management of Acute, Chronic Low Back Pain in Primary Care

06/26/2026

Anthony Calabro, MA

Using real-world patient scenarios and current guideline recommendations, this session from Practical Updates in Primary Care outlines a structured primary care approach to diagnosing low back pain,...

06/26/2026

FDA Approval

pills spilled on the table

FDA Approval

FDA Approves Belzutifan (Welireg) Plus Pembrolizumab (Keytruda) for Adjuvant Treatment of Clear Cell Renal Cell Carcinoma

06/25/2026

Anthony Calabro, MA

The FDA approved expanded adjuvant therapy options for adults with renal cell carcinoma with a clear cell component who are at intermediate-high or high risk of recurrence after nephrectomy, with or without...

06/25/2026

Disease State Pillar

books and stethoscope

Disease State Pillar

IgG4-Related Disease: A Primary Care Guide to Diagnosis and Referral

06/25/2026

Anthony Calabro, MA

IgG4-related disease is unlikely to be the first diagnosis suspected in primary care, but PCPs may be the first clinicians to recognize the atypical, recurrent, mass-like, or multiorgan patterns that should...

06/25/2026

Research Summary

IV bag

Research Summary

Cefazolin Noninferior to Flucloxacillin/Cloxacillin for 90-Day Mortality in Adult MSSA Bacteremia

06/25/2026

Anthony Calabro, MA

In an international Bayesian adaptive RCT of adults with MSSA bacteremia, cefazolin was noninferior to flucloxacillin or cloxacillin for 90-day all-cause mortality and was associated with less acute kidney...

06/25/2026

June 2026

Current Issue

June 2026

66

6